Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Other financing activities (2024)

Kairos Pharma's Other financing activities history spans 1 years, with the latest figure at $3000.0 for Q3 2024.

  • For Q3 2024, Other financing activities changed N/A year-over-year to $3000.0; the TTM value through Dec 2024 reached $45000.0, changed N/A, while the annual FY2024 figure was $390000.0, 8.24% down from the prior year.
  • Other financing activities reached $3000.0 in Q3 2024 per KAPA's latest filing, up from -$47000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $89000.0 in Q1 2024 to a low of -$47000.0 in Q2 2024.